Search
Displaying 121–130 of 790 for “retinitis clinical trial”
-
Genentech’s Port Delivery System for Wet AMD Meets Primary Endpoint in Phase 3 Clinical Trial
Research NewsTiny implant provides continual delivery of anti-VEGF treatment for six months
-
First Patient Receives Emerging CRISPR Therapy in Clinical Trial for LCA 10
Research NewsFirst time emerging CRISPR therapy administered inside the human body
-
Research News
Part B of the trial will enroll nine adult patients as well as three pediatric patients.
-
Enhanced Implantable Miniature Telescope Moving into Clinical Trial for AMD Patients
Research NewsThe device is designed for people with late-stage AMD who have no treatment options
-
Twelve People Receive XLRS Gene Therapy in AGTC's Clinical Trial
Research NewsAGTC’s gene therapy uses a human-engineered virus — and adeno-associated virus or AAV — to deliver normal copies of retinoschisin to the patient’s retina.
-
ARVO 2016: Choroideremia Gene Therapy in Clinical Trial Continues to Perform Well
Research NewsFive of six patients in NightStaRx’s choroideremia gene-therapy trial continue to benefit from the treatment.
-
Opus Genetics Receives FDA Clearance to Launch Clinical Trial for Best1 Gene Therapy
Research NewsThe Foundation funded earlier, proof-of-concept studies for the Best1 gene therapy and later launched Opus to develop several IRD gene therapies.
-
Neurogene to Launch Gene Therapy Clinical Trial for Children with Batten Disease
Research NewsThe treatment will be delivered to the vitreous of the eye and ventricles of the brain
-
Research News
The emerging treatment targets a specific mutation (c.2991+1655A>G in Intron 26) of the gene CEP290 which causes Leber congenital amaurosis 10 (LCA 10)
-
Opus Genetics Launches Gene Therapy Clinical Trial for Best Disease
Research NewsThe Foundation funded preclinical studies for the approach and launched Opus.
